Anti-B Lymphocytotoxins in Renal-Allograft Rejection

Authors:
  • RERobert B. Ettenger
    Robert B. Ettenger
  • PTPaul I. Terasaki
    Paul I. Terasaki
  • ATAlan Ting
    Alan Ting
  • MMMohammed H. Malekzadeh
    Mohammed H. Malekzadeh
  • APAlfred J. Pennisi
    Alfred J. Pennisi
  • CUChristel Uittenbogaart
    Christel Uittenbogaart
  • RGRobert Garrison
    Robert Garrison
  • RFRichard N. Fine
    Richard N. Fine

Abstract
To determine the possible role of the B lymphocyte alloantigen system in renal-transplant rejection, we examined serum specimens from 81 allograft recipients for cytotoxic activity against a panel of normal B lymphocytes. Specimens from 22 of 25 recipients undergoing allograft rejection demonstrated strong B-lymphocyte cytotoxicity whereas only 13 of 56 recipients with normal allograft function showed similar B lymphocyte cytotoxicity (P<0.0001). In the serum samples of recipients with graft rejection who were followed sequentially, B-lymphocyte cytotoxicity preceded or was concurrent with the onset of functional impairment. The results show that anti-B-lymphocyte antibodies are associated with rejection, but it is quite possible that they are the products of rejection rather than the cause. (N Engl J Med 295:305–309, 1976)

This publication has 19 references indexed in Scilit: